Hemodynamic Control of Atrial Natriuretic Peptide Plasma Levels in Neonatal Respiratory Distress Syndrome

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Perinatology

• Publication date

  1995-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2007-994461PMID 7575823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome.

  1994cited by this paper
• Early changes in the neonatal circulatory transition.

  1993cited by this paper
• Central venous pressure in the ventilated neonate.

  1992cited by this paper
• Atrial natriuretic peptide in the preterm infant. Lack of correlation with natriuresis and diuresis

  1992cited by this paper
• Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus

  1992cited by this paper
• Atrial natriuretic peptide during early human development.

  1991cited by this paper
• Correlation of Patent Ductus Arteriosus Shunting with Plasma Atrial Natriuretic Factor Concentration in Preterm Infants with Respiratory Distress Syndrome

  1990cited by this paper
• Pulmonary Vascular Effects of Exogenous Atrial Natriuretic Peptide in Sheep Fetuses

  1990cited by this paper
• Interrelationship of atrial natriuretic peptide, atrial volume, and renal function in premature infants.

  1990cited by this paper
• Alveolar hypoxia is a powerful stimulus for ANF release in conscious lambs.

  1989cited by this paper
• Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia.

  1988influential reference
• NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life.

  1988cited by this paper
• Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats.

  1988cited by this paper
• Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man.

  1988cited by this paper
• Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension.

  1987cited by this paper
• Influence of Dopamine on Atrial Natriuretic Peptide Level in Premature Infants

  1987cited by this paper
• Elevated atrial natriuretic factor in neonates with respiratory distress syndrome.

  1986cited by this paper
• Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not vein.

  1986cited by this paper
• Comparison of Plasma Atrial Natriuretic Peptide Levels in Healthy Children from Birth to Adolescence and in Children with Cardiac Diseases1

  1986cited by this paper
• Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids.

  1985cited by this paper
• Atrial natriuretic factor—a circulating hormone stimulated by volume loading

  1985cited by this paper
• Cellular mechanism of release of atrial natriuretic factor.

  1984cited by this paper
• Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria.

  1983cited by this paper
• Cardiovascular monitoring in infants with respiratory distress syndrome.

  1983cited by this paper
• Studies on the circulation in the neonatal period. The circulation in the respiratory distress syndrome.

  1961cited by this paper

• Pulmonary disease of the newborn

  2012cites this paper
• Chapter 11 – Renal Modulation: Arginine Vasopressin and Atrial Natriuretic Peptide

  2012cites this paper
• Stable Precursor Fragments of Vasoactive Peptides in Umbilical Cord Blood of Term and Preterm Infants

  2011cites this paper
• Plasma Natriuretic Peptides As Predictors of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates

  2010cites this paper
• Renal modulation: arginine vasopressin and atrial natriuretic peptide

  2008cites this paper
• In vivo Dilatation of the Postnatal Ductus Arteriosus by Atrial Natriuretic Peptide in the Rat

  2007cites this paper
• pressure in neonatal respiratory distress syndrome? monophosphate production responsible for low blood Is carbon monoxide-mediated cyclic guanosine

  2006cites this paper
• Is carbon monoxide-mediated cyclic guanosine monophosphate production responsible for low blood pressure in neonatal respiratory distress syndrome?

  2005cites this paper
• Nitric Oxide Production and Plasma Cyclic Guanosine Monophosphate in Premature Infants with Respiratory Distress Syndrome

  2002cites this paper
• Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants

  2001cites this paper
• Usefulness of Plasma Atrial Natriuretic Peptide Concentration in the Diagnosis of Patent Ductus Arteriosus in Preterm Infants

  2000cites this paper
• Elevation of atrial natriuretic peptide prohormone. Hemodynamic background of the elevation of N-terminal natriuretic peptide prohormone in children with congenital heart disease

  1999cites this paper